Anergy in Experimental Mouse Models of Mycobacterial Infection

  • Ian M. Orme
Part of the Infectious Agents and Pathogenesis book series (IAPA)


Unresponsiveness, or anergy, is often observed in association with active tuberculosis and other mycobacterial diseases, both in the clinical setting and in experimental animal models of these infections. In both clinical and experimental laboratory settings, various manifestations of anergy can be observed using both in vitro and in vivo approaches. In the case of the former, most in vitro observations of anergy following mycobacterial infection consist of the measurement of a reduced capacity of lymphocytes to undergo blastogenic transformation in response to stimulation by mitogens, by specific antigens associated with the infecting organism, or by alloantigens in a mixed lymphocyte culture. As for in vivo expressions of anergy, these are most usually measured as a reduction or loss of the capacity of the infected host to mount a delayed-type hypersensitivity (DTH) response to a cutaneous injection of specific antigen.


Spleen Cell Infected Mouse Mycobacterial Infection Mycobacterium Bovis Mixed Lymphocyte Culture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Florentin, I., Huchet, R., Bruly-Rosset, M., Halle-Pannenko, O., and Mathe, G., 1976, Studies on the mechanisms of action of BCG, Cancer Immunol. Immunother. 1:31–39.Google Scholar
  2. 2.
    Turcotte, R., Lafleur, L., and Lebreche, M., 1978, Opposite effects of BCG on spleen and lymph node cells: Lymphocyte proliferation and immunoglobulin synthesis, Infect. Immun. 21:696–704.PubMedGoogle Scholar
  3. 3.
    Turcotte, R., 1981, Evidence for two distinct populations of suppressor cells in the spleens of Mycobacterium bovis BCG-sensitized mice, Infect. Immun. 34:315–322.PubMedGoogle Scholar
  4. 4.
    Turcotte, R., and Lemieux, S., 1982, Mechanisms of action of Mycobacterium bovis BCG-induced suppressor cells in mitogen-induced blastogenesis, Infect. Immun. 36:263–270.PubMedGoogle Scholar
  5. 5.
    Klimpel, G. R., and Henney, C. S. ,1978, BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro, J. Immunol. 120:563–569.PubMedGoogle Scholar
  6. 6.
    Orbach-Arbouys, S. ,and Poupon, M. F., 1978, Active suppression of in vitro reactivity of spleen cells after BCG treatment, Immunology 34:431–437.PubMedGoogle Scholar
  7. 7.
    Bullock, W. E., Carlson, E. M., and Gershon, R. K., 1978, The evolution of immunosuppressive cell populations in experimental mycobacterial infection, J. Immunol. 120:1709–1716.PubMedGoogle Scholar
  8. 8.
    Bennett, J. A., and Marsh, J. C., 1980, Relationship of Bacillus Calmette-Guérin-induced suppressor cells to hematopoietic precursor cells, Cancer Res. 40:80–85.PubMedGoogle Scholar
  9. 9.
    Rook, G. A. W., and King, J., 1978, Is the adherent non-specific “suppressor” cell from rodent spleens an in vitro artifact?, Clin. Exp. Immunol. 32:466–471.PubMedGoogle Scholar
  10. 10.
    Riglar, C., and Cheers, C., 1980, Macrophage activation during experimental murine brucellosis. II. Inhibition of in vitro lymphocyte proliferation by Brucella-activated macrophages, Cell. Immunol. 49: 149–154.CrossRefGoogle Scholar
  11. 11.
    Cheers, C., Pavlov, H., Riglar, C., and Madraso, E., 1980, Macrophage activation during experimental murine brucellosis. III. Do macrophages exert feedback control during brucellosis?, Cell. Immunol. 49:166–181.CrossRefGoogle Scholar
  12. 12.
    Wepsic, H. T., Alaimo, J., Druker, B. J., Murray, W., and Morris, H. P., 1981, The negative systemic effects of BCGcw inoculated intraperitoneally. I. In vivo demonstration of intramuscular tumor growth enhancement using Morris hepatomas, Cancer Immunol. Immunother. 10:217–227.CrossRefGoogle Scholar
  13. 13.
    Druker, B. J., Wepsic, H. T., 1983, BCG-induced macrophages as suppressor cells, Cancer Invest. 1: 151 -161.PubMedCrossRefGoogle Scholar
  14. 14.
    Orme, I. M., Stokes, R. W., and Collins, F. M., 1986, Genetic control of natural resistance to nontuberculous mycobacterial infections in mice, Infect. Immun. 54:56–62.PubMedGoogle Scholar
  15. 15.
    Orme, I. M., and Collins, F. M., 1984, Immune response to atypical mycobacteria: Immunocompetence of heavily infected mice measured in vivo fails to substantiate immunosuppression data obtained in vitro, Infect. Immun. 43:32–37.PubMedGoogle Scholar
  16. 16.
    Orme, I. M., and Collins, F. M., 1984, Demonstration of acquired resistance in Bcgr inbred mouse strains infected with a low dose of BCG Montreal, Clin. Exp. Immunol. 56:81–88.PubMedGoogle Scholar
  17. 17.
    Orme, I. M., and Collins, F. M., 1983, Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy, J. Exp. Med. 158:74–83.PubMedCrossRefGoogle Scholar
  18. 18.
    Orme, I. M., Ratcliffe, M. J. H., and Collins, F. M., 1984, Acquired immunity to heavy infection with Mycobacterium bovis bacillus Calmette-Guerin and its relationship to the development of nonspecific unresponsiveness in vitro, Cell. Immunol. 87:285–296.CrossRefGoogle Scholar
  19. 19.
    Orme, I. M., and Collins, F. M., 1984, Adoptive protection of the Mycobacterium tuberculosis-infected lung, Cell, Immunol. 84:113–120.CrossRefGoogle Scholar
  20. 20.
    Colizzi, V., 1984, In vivo and in vitro administration of interleukin 2-containing preparations reverses T cell-unresponsiveness in Mycobacterium bovis BCG-infected mice, Infect Immun. 45:25–28.PubMedGoogle Scholar
  21. 21.
    Turcotte, R., and Legault, D., 1986, Mechanisms underlying the depressed production of interleukin-2 in spleen and lymph node cell cultures of mice infected with Mycobacterium bovis BCG, Infect. Immun. 51:826–831.PubMedGoogle Scholar
  22. 22.
    Allison, A. C., 1978, Mechanisms by which activated macrophages inhibit lymphocyte responses, Immunol. Rev. 40:3–24.PubMedCrossRefGoogle Scholar
  23. 23.
    Zinsser, H., 1921, Studies on the tuberculin reaction and on specific hypersensitiveness in bacterial infection, J. Exp. Med. 34:495–524.PubMedCrossRefGoogle Scholar
  24. 24.
    Collins, F. M. ,and Mackaness, G. B., 1970, The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice, Cell. Immunol. 1:253–265.PubMedCrossRefGoogle Scholar
  25. 25.
    Turcotte, R., and Forget, A. ,1983, Cutaneous unresponsiveness to Mycobacterium bovis BCG in intravenously infected mice, Infect. Immun. 41:453–461.PubMedGoogle Scholar
  26. 26.
    Lamoreux, G. ,and Poisson, R., 1974, B.C.G. and immunological anergy, Lancet 1:989– 990.CrossRefGoogle Scholar
  27. 27.
    Sprent, Miller, J. F. A. P., and Mitchell, G. F., 1970, Antigen-induced selective recruitment of circulating lymphocytes, Cell, Immunol. 2:171–181.CrossRefGoogle Scholar
  28. 28.
    Schlossman, S. F., Levin, H. A., Rocklin, R. E., and David, J. R., 1971, The compart-mentalization of antigen-reactive lymphocytes in desensitized guinea pigs, J. Exp. Med. 134:741–750.PubMedCrossRefGoogle Scholar
  29. 29.
    Dwyer, J. M., and Kantor, F. S., 1973, Regulation of delayed hypersensitivity. Failure to transfer delayed type hypersensitivity to desensitized guinea pigs, J. Exp. Med. 137:42.CrossRefGoogle Scholar
  30. 30.
    Bullock, W. E., 1975, Anergy and infection, Adv. Intern. Med. 21:149.Google Scholar
  31. 31.
    Bullock, W. E., 1978, Leprosy: A model of immunological perturbation in chronic infection, J. Infect. Dis. 137:341–345.PubMedCrossRefGoogle Scholar
  32. 32.
    Bullock, W. E., 1976, Perturbation of lymphocyte circulation in experimental murine leprosy. I. Description of the defect, J. Immunol. 117: 1164–1170.PubMedGoogle Scholar
  33. 33.
    Orme, I. M., and Collins, F. M., 1984, Passive transfer of tuberculin sensitivity from anergic mice, Infect. Immun. 46:850–853.PubMedGoogle Scholar
  34. 34.
    Campa, M., Benedettini, G., and Marelli, P., 1986, B and T lymphocytes regulated by idiotype anti-idiotype interactions inhibit delayed-type hypersensitivity to BCG in mice, Cell. Immunol. 98:93–103.PubMedCrossRefGoogle Scholar
  35. 35.
    Brown, C. A., Brown, I. N., and Sljivic, V. S., 1979, Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: Importance of BCG viability, Immunology 38:481–488.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Ian M. Orme
    • 1
  1. 1.Department of Microbiology and Environmental Health, School of Veterinary MedicineColorado State UniversityFort CollinsUSA

Personalised recommendations